The inflammatory response of human pancreatic cancer samples compared to normal controls

Pancreatic ductal adenocarcinoma (PDAC) is a poor prognosis cancer with an aggressive growth profile that is often diagnosed at late stage and that has few curative or therapeutic options. PDAC growth has been linked to alterations in the pancreas microbiome, which could include the presence of the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2023-11, Vol.18 (11), p.e0284232-e0284232
Hauptverfasser:	Brayer, Kathryn J, Hanson, Joshua A, Cingam, Shashank, Martinez, Cathleen, Ness, Scott A, Rabinowitz, Ian
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Adenocarcinoma Analysis B cells Biology and Life Sciences Cancer Carcinoma, Pancreatic Ductal - pathology Care and treatment Complement activation Complement system Development and progression Diagnosis Gene expression Gene Expression Regulation, Neoplastic Gene sequencing Gene set enrichment analysis Genes Genomes Health aspects Humans Immune response Immune system Inflammation Inflammatory response Kinases Malassezia Medical prognosis Medicine and Health Sciences Microbiomes Mutation Pancreas - pathology Pancreatic cancer Pancreatic Neoplasms - pathology Patients Prognosis Ribonucleic acid RNA RNA - metabolism Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!